Description �� Description Adenosine Monophosphate (AMP) is a nucleotide composed of an adenine base, ribose sugar, and one phosphate group. It plays a role in various biochemical pathways, including energy metabolism, RNA synthesis, and as a precursor to other nucleotides like ADP and ATP. In clinical or veterinary use, AMP may be used for: Energy metabolism support Muscle recovery Cellular regeneration Potential immune or anti-inflammatory support (investigational) Formulation: Concentration: 30 mg/mL Route: Typically intramuscular (IM) or subcutaneous (SC) injection Commonly available in vials for injection �� Dosage & Administration Dosage depends on the indication and species (human or veterinary), but generally: Humans (off-label/nutritional use): 1–2 mL IM, 1–2 times per week (depending on clinical judgment) Veterinary use (e.g., horses, dogs): Horses: 5–10 mL IM or SC Dogs/Cats: 0.5–2 mL IM or SC Frequency: Once daily or every other day, usually in cycles Note: AMP is not widely approved by regulatory bodies like the FDA for direct human therapeutic use, except in research or nutraceutical contexts. Consult a healthcare professional before use. ⚠️ Side Effects Though generally considered safe at recommended doses, possible side effects include: Common (mild) Local irritation at injection site Mild fatigue Headache Nausea or mild GI upset Rare (moderate-severe) Allergic reaction (rash, itching, swelling) Hypotension (in high doses) Tachycardia or palpitations (if AMP is rapidly metabolized to adenosine) Dyspnea or chest discomfort (rare, typically at very high doses) �� Pharmacokinetics AMP is a naturally occurring compound, so its metabolism and clearance are relatively rapid and integrated with normal cellular processes. Absorption: Rapid after IM or SC administration Distribution: Widely distributed across tissues; quickly taken up by cells Metabolism: Primarily in the liver and cells, converted to adenosine, ADP, and ATP Adenosine is then further broken down by adenosine deaminase to inosine Elimination half-life: Very short (minutes), especially once converted to adenosine Excretion: Metabolites are excreted in urine (e.g., hypoxanthine, uric acid) �� Additional Notes Drug Interactions: Minimal, but theoretically may interact with adenosine antagonists (like caffeine, theophylline) or antihypertensives Contraindications: Known hypersensitivity Severe hypotension or bradycardia Active infection or inflammation at injection site Pregnancy/Lactation: Safety not well-established
